AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

SANDOZ TO STRENGTHEN DANISH MARKET POSITION AND NORDIC OPS.

AsiaPulse News

| July 01, 2004 | COPYRIGHT 2004 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(Full text of a statement. Contact details below)

VIENNA, Austria, June 30/PR Newswire-AsiaNet/ - Sandoz today announced the acquisition of Durascan, the generic subsidiary of Astra Zeneca in Denmark, in a transaction aimed at claiming the number two position in the Danish generics market and establishing a new operational hub in the Nordic region. Financial details of the transaction were not disclosed.

With net sales of EUR25 million in 2003, Durascan has a broad portfolio of generic medicines that provide growth opportunities for Sandoz throughout the Nordic region. In addition, Durascan provides Sandoz with state-of-the-art quality assurance and logistics facilities, making it an attractive operational platform to fuel regional growth.

"The acquisition of Durascan provides Sandoz with a leadership position in the Danish generics market and a platform to increase our presence in the Nordic region with its strong and highly competitive generics environment," said Christian Seiwald, CEO of Sandoz. "It is perfectly in line with our strategy to grow organically, while seeking selected regional or therapeutic acquisitions." Company Information

Sandoz, a Novartis company, is a world leader in generic pharmaceuticals and develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredients. Decades of experience and profound know-how make Sandoz a renowned partner in the Franchises Pharmaceuticals, Biopharmaceuticals and Industrial Products. Altogether, Sandoz employs around 13,000 people worldwide and posted sales of USD 2.9 billion in 2003.

Novartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer health. In 2003, the Group's businesses achieved sales of USD 24.9 billion and a net income of USD 5.0 billion. The Group invested approximately USD 3.8 billion in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ about 78,500 people and operate in over 140 countries around the world. For further information please consult http://www.novartis.com.

This release contains certain "forward-looking statements" relating to the Company's business, which can ...

Related articles from newspapers, magazines, journals, and more
SANDOZ LTD. PROPOSES NEW BOARD MEMBERS; REPORTS 1992 RESULTS; CHANGES IN GROUP...
Press release article from: PR Newswire March 25, 1993 700+ words
...Barlocher, 51, at present CEO of Sandoz Nutrition Ltd., joined Sandoz in 1973. He was a member of the...operational management in two divisional companies, Dr. Barlocher assumes the post of CEO of Sandoz Pharma Ltd., replacing Dr. Rolf...
SANDOZ LTD. TO ACQUIRE 60 PERCENT OF SYSTEMIX COMMON STOCK
Press release article from: PR Newswire December 16, 1991 700+ words
...Global 500 list of companies. The pharmaceutical division, Sandoz Pharma Ltd., ranks among the 10 leading companies in the pharmaceutical...90-01, all of Sandoz Ltd; or Fred Spar...2655, of Kekst and Company for SyStemix...
SANDOZ-CIBA GEIGY MERGER WOULD CREATE EIGHTH-LARGEST PHARMACEUTICAL FIRM IN U.S.
Press release article from: PR Newswire March 7, 1996 700+ words
...of Swiss-based Sandoz Ltd. and Ciba...largest pharmaceutical company in the U.S...for the combined companies at just under...of Eli Lilly and Company among the 10 largest...percent market share. Sandoz ranked 17th with...
SANDOZ COMMITS TO COOPERATING WITH NIH TO RESOLVE CONCERNS OVER COLLABORATIVE...
Press release article from: PR Newswire June 17, 1993 700+ words
...Sandoz Pharmaceuticals as a "foreign" company. While Sandoz Pharmaceuticals' parent is a Swiss company, the Sandoz presence in the United States is...state of New York in 1919. Sandoz companies in the United States currently employ...
Sandoz Announces Plans to Double Permanent Sales Force
Press release article from: PR Newswire October 1, 1996 700+ words
...nervous system. Sandoz Pharmaceuticals...affiliate of Sandoz, Ltd. of Basel...and nutrition company with additional...healthcare service companies. Innovex is...marketing. The company works with approximately...pharmaceutical companies each year, including...Lenexa, KS. Sandoz ...
SANDOZ TO ACQUIRE GENETIC THERAPY, INC. IN CASH TENDER OFFER VALUED AT USD 295...
Press release article from: PR Newswire July 10, 1995 700+ words
...nutrition." In 1994, Sandoz acquired U.S. baby...manufacturer Gerber Products Company, strengthening its base...billion Swiss francs. Sandoz Ltd. is a global leader...pharmaceuticals and nutrition. The company has operations and affiliates...worldwide. In 1994, Sandoz Ltd. achieved sales...
SANDOZ ESTABLISHES SPONSORED ADR PROGRAM
Press release article from: PR Newswire November 7, 1991 700+ words
...strategic flexibility, Sandoz is prepared to meet...Bischoff said. Sandoz Ltd. is the holding company for six operating divisions...than 50 countries. Sandoz had consolidated sales...Global 500 list of companies. Sandoz Ltd. has...
SANDOZ LTD. TO ACQUIRE THE GERBER PRODUCTS COMPANY; SANDOZ TO COMMENCE TENDER...
Press release article from: PR Newswire May 23, 1994 700+ words
...Gerber Products Company (NYSE: GEB) and Sandoz Ltd., Basel announced...the Gerber Products Company into the Sandoz Group. This transaction...merger with the Wander Company in 1967. With Ovaltine as its base, Sandoz has built a strong...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA